Fig. 2.
Cumulative incidence curves of relapse for 46 patients with previously untreated secondary AML based on PB blast count before the start of the transplant preparative regimen: (1) 0 to 3.0 × 109 cells/L (n = 16); (2) 3.1 to 5.5 × 109 cells/L (n = 15); (3) < 5.5 × 109 cells/L (n = 15).